Search results for "Catheter Ablation"

showing 10 items of 90 documents

Modifications in Ventricular Fibrillation and Capture Capacity Induced by a Linear Radiofrequency Lesion

2012

[EN] Introduction and objectives: An analysis was made of the effects of a radiofrequency-induced linear lesion during ventricular fibrillation and the capacity to capture myocardium through high-frequency pacing. Methods: Using multiple epicardial electrodes, ventricular fibrillation was recorded in 22 isolated perfused rabbit hearts, analyzing the activation maps upon applying trains of stimuli at 3 different frequencies close to that of the arrhythmia: a) at baseline; b) after radio-frequency ablation to induce a lesion of the left ventricular free wall (length=10 [1] mm), and c) after lengthening the lesion (length=23 [2] mm). Results: Following lesion induction, the regularity of the r…

medicine.medical_specialtyRadio Wavesmedicine.medical_treatmentAblationIn Vitro TechniquesTECNOLOGIA ELECTRONICAElectrocardiographyInternal medicinemedicineAnimalsRadiofrequency lesionVentricular fibrillationElectrodesbusiness.industryMyocardiumCardiac Pacing ArtificialGeneral Medicinemedicine.diseaseAblationSurgeryElectrical stimulationRadiofrequencyVentricular FibrillationVentricular fibrillationCatheter AblationCardiologyRabbitsbusinessRevista Española de Cardiología (English Edition)
researchProduct

Endoscopic radiofrequency ablation of a cholangiocarcinoma with targeted intraductal cholangioscopic access.

2020

medicine.medical_specialtyRadiofrequency Ablationbusiness.industryRadiofrequency ablationGastroenterologyMEDLINElaw.inventionCholangiocarcinomaBiliary Tract Surgical ProceduresBile Ducts IntrahepaticBile Duct NeoplasmslawCatheter AblationMedicineHumansRadiologybusinessEndoscopy
researchProduct

Changes in the Spectral Characteristics of Ventricular Fibrillation in Lesions Produced by Radiofrequency Ablation. An Experimental Study

2008

INTRODUCTION AND OBJECTIVES Although electro- physiological databases contain information about changes in the time domain in lesions produced by radiofrequency ablation, very few data on changes in the frequency domain are available. The aim of this study was to investigate changes in the spectral characteristics of ventricular fibrillation in zones with radiofrequency lesions. METHODS Recordings of ventricular fibrillation were obtained in 11 isolated perfused rabbit heart preparations using a multiple epicardial electrode located on the left ventricular free wall. Spectral parameters derived by Fourier analysis before and after the creation of transmural radiofrequency lesions were compa…

medicine.medical_specialtyRadiofrequency ablationHeart VentriclesIn Vitro TechniquesStandard deviationlaw.inventionLesionNuclear magnetic resonancelawInternal medicineAnimalsMedicinebusiness.industrySpectral densityGeneral MedicineDominant frequencymedicine.diseaseMean frequencyFrequency domainVentricular FibrillationVentricular fibrillationCatheter AblationCardiologyRabbitsmedicine.symptombusinessRevista Española de Cardiología (English Edition)
researchProduct

In vitro comparison of platinum-iridium and gold tip electrodes: lesion depth in 4 mm, 8 mm, and irrigated-tip radiofrequency ablation catheters

2009

Aims We compared a newly developed irrigated gold tip electrode ablation catheter and a gold tip 4 and 8 mm catheter with the corresponding platinum–iridium (Pt) tip catheters in an in vitro setting. Methods and results In a flow chamber simulating physiological flow conditions, radiofrequency catheter ablation was performed on tissue samples of porcine endomyocardium and liver. Lesion depth, energy and temperature delivery, and popping frequency were determined. Two hundred and fifty-three ablations were conducted. Four and eight millimetre, gold tip electrode catheters produced significantly deeper lesions compared with the Pt tip electrode (liver 4 mm: 4.67 ± 1.7 vs. 2.9 ± 1.0 mm, P < 0.…

medicine.medical_specialtySwineRadiofrequency ablationmedicine.medical_treatmentchemistry.chemical_elementIn Vitro TechniquesIridiumlaw.inventionlawPhysiology (medical)medicineAnimalsIridiumCardiac Surgical ProceduresElectrodesPlatinumbusiness.industryLesion depthAblationSurgeryCatheterLiverchemistryRadiofrequency catheter ablationModels AnimalElectrodeCatheter AblationGoldCardiology and Cardiovascular MedicinePlatinumbusinessNuclear medicineEuropace
researchProduct

Renal artery denervation for treating resistant hypertension: Definition of the disease, patient selection and description of the procedure

2012

Arterial hypertension is responsible for a significant burden of cardiovascular morbidity and mortality, worldwide. Although several rational and integrated pharmacological strategies are available, the control of high blood pressure still remains largely unsatisfactory. Failure to achieve effective blood pressure control in treated hypertensive patients may have a substantial impact on individual global cardiovascular risk, since it significantly increases the risk of developing hypertension-related macrovascular and microvascular complications. Arterial hypertension is arbitrarily defined as 'resistant' or 'refractory' when the recommended blood pressure goals (clinic blood pressure below…

medicine.medical_specialtySympathetic nervous systemSettore MED/09 - Medicina InternahypertensionDrug ResistanceFemoral arteryRisk AssessmentNephropathyPharmacotherapyRenal ArteryRisk Factorsmedicine.arteryInternal medicinemedicineInternal MedicineHumansArterial PressureRenal arterySympathectomyrenal artery denervationglobal cardiovascular riskantihypertensive therapyAntihypertensive AgentsSettore MED/14 - NefrologiaDenervationrefractory hypertensiontreatmentbusiness.industryPatient SelectionType 2 Diabetes Mellitusresistant hypertensionmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structureBlood pressureTreatment Outcomeresistant hypertension refractory hypertension renal artery denervation antihypertensive therapy global cardiovascular risk.resistant-hypertension; treatment; hypertensionCardiologyCatheter AblationHypertension treatment; Resistant-hypertension treatment; Antihypertensive Agents; Humans; Hypertension; Patient Selection; Renal Artery; Risk Assessment; Risk Factors; Sympathectomy; Treatment Outcome; Arterial Pressure; Catheter Ablation; Drug Resistance; Internal Medicine; Cardiology and Cardiovascular MedicinebusinessCardiology and Cardiovascular Medicineresistant-hypertension
researchProduct

ESH position paper: renal denervation - an interventional therapy of resistant hypertension

2012

Experts from the European Society of Hypertension prepared this position paper in order to summarize current evidence, unmet needs and practical recommendations on the application of percutaneous transluminal ablation of renal nerves [renal denervation (RDN)] as a novel therapeutic strategy for the treatment of resistant hypertension. The sympathetic nervous activation to the kidney and the sensory afferent signals to the central nervous system represent the targets of RND. Clinical studies have documented that catheter-based RDN decreases both efferent sympathetic and afferent sensory nerve traffic leading to clinically meaningful systolic and diastolic blood pressure (BP) reductions in pa…

medicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemSystolePhysiologyCentral nervous systemCardiologyKidneyNeurosurgical ProceduresRenal ArteryDiastoleInternal medicineInternal MedicinemedicineHumansSystoleIntensive care medicineSocieties MedicalAgedRandomized Controlled Trials as TopicDenervationKidneybusiness.industryresistant hypertensionMiddle AgedDenervationEuropeTreatment OutcomeBlood pressuremedicine.anatomical_structureHypertensionCatheter AblationCardiologyPosition paperRenal denervationCardiology and Cardiovascular MedicinebusinessSensory nerve
researchProduct

Impact of Structural Heart Disease on the Acute Complication Rate in Atrial Fibrillation Ablation: Results from the German Ablation Registry

2013

Acute Complication Rate in AF Ablation Introduction Catheter ablation (CA) has emerged as a widespread therapeutic option in the treatment of atrial fibrillation (AF). Currently, no safety data with regard to the impact of the underlying structural heart diseases (SHD) are available. We sought to assess the risk for acute and long-term complications during CA of AF in relation to underlying SHD. Methods and Results We included 6,211 patients in a prospective registry undergoing CA of AF in 41 nationwide centers. All patients were divided into 4 groups according to the underlying heart disease: No SHD (69.4%), hypertensive heart disease (HHD) (12.0%), coronary artery disease (CAD) (15.1%), a…

medicine.medical_specialtyUnivariate analysisHeart diseasebusiness.industrymedicine.medical_treatmentCardiomyopathyAtrial fibrillationCatheter ablationOdds ratiomedicine.diseaseHypertensive heart diseaseCoronary artery diseasePhysiology (medical)Internal medicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Electrophysiology
researchProduct

Direct Oral Anticoagulants in the Setting of Catheter Ablation of Atrial Fibrillation: State of art

2021

Atrial fibrillation (AF) represents the arrhythmia of greatest clinical impact and catheter ablation of AF (CAAF) has become the most effective strategy for rhythm control in selected patients. Therefore, appropriate anticoagulation strategies are of paramount importance for patients undergoing CAAF, especially those at high risk, such those with high CHA2DS2VASc scores. Optimal management of anticoagulation before, during, and after CAAF is crucial. Several studies have evaluated the use of different anticoagulation strategies in the periprocedural period. Randomized controlled trial seem to suggest that in patients undergoing CAAF, uninterrupted (or minimally interrupted) direct oral anti…

medicine.medical_specialtyVitamin Kmedicine.medical_treatmentAdministration OralRhythm controlCatheter ablation030204 cardiovascular system & hematologyVitamin klaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineVitamin K/administration & dosagecatheter ablationmedicineHumansrisk factorsIn patientatrial fibrillation030212 general & internal medicineanticoagulationRandomized Controlled Trials as TopicAnticoagulants/administration & dosagebusiness.industryAnticoagulantsAtrial fibrillationGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareOptimal managementTreatment OutcomeState of artCardiologybusinessCardiology and Cardiovascular MedicineAtrial Fibrillation/complications
researchProduct

Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus &lt;75 Years-Results from the German Ablation Regist…

2017

Age-Related Complication Rates in AF AblationIntroduction Despite a rising demand for catheter ablation (CA) of atrial fibrillation (AF) in an elderly population, complication and success rates are not fully elucidated. We sought to compare complication rates of CA of AF in patients ≥75 versus <75 years of age. Methods and Results Patients with symptomatic, drug-refractory AF were prospectively enrolled from January 2007 to 2010 in this multicenter study. A total of 4,449 patients, group 1 ≥75 years and group 2 <75 years (n = 227, age 77.3 ± 2.2 vs. 59.7 ± 9.8 years, 52.0% vs. n = 4,222, 68.9% male, CHA2DS2-VASc-Score 3.7 ± 1.0 vs. 1.7 ± 1.2; P < 0.001, respectively), with paroxysmal AF (59…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCatheter ablationAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseAblationSurgery03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineCohortmedicineCardiologyIn patient030212 general & internal medicineMyocardial infarctionCardiology and Cardiovascular MedicinebusinessComplicationStrokeJournal of Cardiovascular Electrophysiology
researchProduct

Stepwise Approach to Atrial Fibrillation Mapping and Ablation in Persistent and Long-standing Persistent Atrial Fibrillation

2019

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentInternal medicinePersistent atrial fibrillationmedicineCardiologyCatheter ablationAtrial fibrillationAblationmedicine.diseasebusinessStepwise approach
researchProduct